Effects of quinupristin and dalfopristin injection: A Synthesis of Findings from 23 Studies
- Home
- Effects of quinupristin and dalfopristin injection
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of quinupristin and dalfopristin injection: A Synthesis of Findings from 23 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Major Research Findings
Quinupristin/dalfopristin is a new injectable streptogramin antibiotic that has shown promise in treating infections caused by multi-drug resistant bacteria. 21 The drug works by inhibiting protein synthesis in bacteria, which ultimately stops bacterial growth. 21 This drug has demonstrated efficacy against a range of bacteria including *Streptococcus pneumoniae*, *Staphylococcus aureus*, and *Enterococcus faecium*. 21 Studies have also shown that quinupristin/dalfopristin is effective against vancomycin-resistant *Enterococcus faecium* (VREF) strains, which are difficult to treat with other antibiotics. 6 7 It is important to note that while the drug is generally effective, its efficacy can be compromised in cases of meningitis, particularly when the cerebrospinal fluid is inflamed. 2 13 The drug has also shown synergistic effects with certain antibiotic combinations, especially with beta-lactams. 12 14
Benefits and Risks
Benefits Summary
Quinupristin/dalfopristin offers several benefits, including its effectiveness against multi-drug resistant bacteria, particularly VREF strains. 6 7 Its broad-spectrum activity against various bacteria, including *Streptococcus pneumoniae*, *Staphylococcus aureus*, and *Enterococcus faecium*, makes it a valuable tool in combating bacterial infections. 21
Risk Summary
While quinupristin/dalfopristin shows promise, there are potential risks associated with its use. The drug is administered intravenously, which carries the risk of irritation and inflammation of the veins. 4 It can also cause liver damage and a decrease in platelet count, although these side effects are rare. 4
Comparison Between Studies
Similarities Between Studies
The studies consistently demonstrate the effectiveness of quinupristin/dalfopristin against various Gram-positive bacteria, including multi-drug resistant strains. 3 12
Differences Between Studies
While most studies highlight the overall effectiveness of quinupristin/dalfopristin, some specifically mention its effectiveness against particular bacteria or in specific contexts. For example, studies examining the use of quinupristin/dalfopristin against *Streptococcus pneumoniae* in meningitis indicate that its effectiveness can be reduced when the cerebrospinal fluid is inflamed. 2 13
Consistency and Discrepancies in Results
The studies generally agree on the effectiveness of quinupristin/dalfopristin in treating infections caused by various Gram-positive bacteria, particularly multi-drug resistant strains. 3 12 However, some studies emphasize the importance of considering the context of the infection. For instance, in cases of meningitis, the effectiveness of the drug can be compromised when the cerebrospinal fluid is inflamed. 2 13
Application to Real-life Situations
Quinupristin/dalfopristin is a promising drug for treating infections caused by multi-drug resistant bacteria. However, it is important to be aware of the potential risks associated with its use, including the possibility of vein irritation, liver damage, and decreased platelet count. 4
Limitations of Current Research
While the current research provides valuable insights into the potential of quinupristin/dalfopristin, it is important to note that further research is needed to fully understand the drug's efficacy and potential side effects. More studies are required to investigate the drug's effectiveness against specific infections in different contexts and to explore the potential synergistic effects with other antibiotics. 14
Future Research Directions
Future research should focus on investigating the effectiveness of quinupristin/dalfopristin in specific infections, particularly those associated with inflammation. 2 13 Further exploration of potential synergistic effects with other antibiotics is also crucial. 12 14
Conclusion
Quinupristin/dalfopristin is a promising new injectable streptogramin antibiotic that has demonstrated efficacy against a range of bacteria, including multi-drug resistant strains. 21 6 However, it is important to be aware of the potential risks associated with its use, including the possibility of vein irritation, liver damage, and decreased platelet count. 4 Further research is needed to better understand the drug's efficacy and potential side effects.
Benefit Keywords
Risk Keywords
Article Type
Author: KarbwangJ, DavisT M, LooareesuwanS, MoluntoP, BunnagD, WhiteN J
Language : English
Author: TarasiA, DeverL L, TomaszA
Language : English
Author: RubinsteinE, BompartF
Language : English
Language : English
In-vitro activity of RP 59500, a new semisynthetic injectable pristinamycin against staphylococci.
Author: von EiffC, PetersG
Language : English
Author: GrayJ W, DarbyshireP J, BeathS V, KellyD, MannJ R
Language : English
Author: WilliamsonJohn C, GlazierSteven S, PeacockJames E
Language : English
Author: NakashioS, IwasawaH, IinoS, ShimadaJ
Language : Japanese
Author: BonfiglioG, FurneriP M
Language : English
Author: PechèreJ C
Language : English
Author: JamjianC, BarrettM S, JonesR N
Language : English
Author: VouillamozJ, EntenzaJ M, FégerC, GlauserM P, MoreillonP
Language : English
Author: KanchanapoomTermkiat, KoiralaJanak, GoodrichJames, AgamahEdem, KhardoriNancy
Language : English
Author: MoreillonP
Language : French
Language : English
Author: WalzerP D, AshbaughA, CollinsM, CushionM T
Language : English
Author: GhiselliR, GiacomettiA, CirioniO, MocchegianiF, OrlandoF, Del PreteM, D'AmatoG, ScaliseG, SabaV
Language : English
Author: ChantC, RybakM J
Language : English
Author: LozniewskiA, LionC, MoryF, WeberM
Language : English
Author: SgarabottoDino, CusinatoRiccardo, NarneElena, ScanoFabio, ZignolMatteo, GambinoAntonio, CattelanAnnamaria, MeneghettiFrancesco, CadrobbiPaolo
Language : English
Author: BarrièreJ C, BerthaudN, BeyerD, Dutka-MalenS, ParisJ M, DesnottesJ F
Language : English
Author: BarrièreJ C, BouanchaudD H, ParisJ M, RolinO, HarrisN V, SmithC
Language : English
Author: BouanchaudD H
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.